scholarly journals Evaluation of the Equivalence of Different Intakes of Fruitflow® in Affecting Platelet Aggregation and Thrombin Generation Capacity in a Randomized, Pilot Study in Male Subjects

Author(s):  
Ranjit K Das ◽  
Tanushree Datta ◽  
Dipankar Biswas ◽  
Ruedi Duss ◽  
Niamh O'Kennedy ◽  
...  

Abstract BackgroundWe aimed to investigate the range of intakes linked to efficacy and to make an initial assessment of variability in response to the water-soluble tomato extract, Fruitflow®. Platelet response to ADP agonist and thrombin generation capacity were monitored at baseline and 24h after consuming 0,30,75,150,300mg of Fruitflow® in a randomized, double-blinded crossover study in male subjects 30–65 years of age (n=12, ISRCTN53447583,24/02/2021). ResultsResults showed that the changes from baseline aggregation (-12.0±13.9 to -17.7±15.7%) and thrombin generation (-8.6±4.1 to -11.3±2.3%) achieved for the 75mg, 150mg, and 300mg supplements were equivalent. Effects observed for 0 mg and 30mg supplements were non-equivalent to150mg and not different from baseline (aggregation changed by -0.7±10.2 to 3.0±5.0%, thrombin generation by 0.8±3.1%). ConclusionsThe data suggest that the efficacious range for Fruitflow® lies between 75mg and 300mg, depending on the individual. It may be pertinent to personalize the daily intake of Fruitflow® depending on individual platelet response.

BMC Nutrition ◽  
2021 ◽  
Vol 7 (1) ◽  
Author(s):  
Ranjit K. Das ◽  
Tanushree Datta ◽  
Dipankar Biswas ◽  
Ruedi Duss ◽  
Niamh O’Kennedy ◽  
...  

Abstract Background The water-soluble tomato extract, Fruitflow® is a dietary antiplatelet which can be used to lower platelet aggregability in primary preventative settings. We carried out a pilot study to investigate the range of intakes linked to efficacy and to make an initial assessment of variability in response to Fruitflow®. Methods Platelet response to adenosine diphosphate (ADP) agonist and thrombin generation capacity were monitored at baseline and 24 h after consuming 0, 30, 75, 150 or 300 mg of Fruitflow® in a randomized, double-blinded crossover study in male subjects 30–65 years of age (N = 12). Results were evaluated for equivalence to the standard 150 mg dose. Results Results showed that the changes from baseline aggregation and thrombin generation observed after the 75 mg, 150 mg, and 300 mg supplements were equivalent. Aggregation was reduced from baseline by − 12.9 ± 17.7%, − 12.0 ± 13.9% and − 17.7 ± 15.7% respectively, while thrombin generation capacity fell by − 8.6 ± 4.1%, − 9.2 ± 3.1% and − 11.3 ± 2.3% respectively. Effects observed for 0 mg and 30 mg supplements were non-equivalent to 150 mg and not different from baseline (aggregation changed by 3.0 ± 5.0% and − 0.7 ± 10.2% respectively, while thrombin generation changed by 0.8 ± 3.0% and 0.8 ± 3.1% respectively). Conclusions The data suggest that the efficacious range for Fruitflow® lies between 75 mg and 300 mg, depending on the individual. It may be pertinent to personalize the daily intake of Fruitflow® depending on individual platelet response. Trial registration ISRCTN53447583, 24/02/2021.


Nutrients ◽  
2021 ◽  
Vol 13 (7) ◽  
pp. 2184
Author(s):  
Niamh O’Kennedy ◽  
Ruedi Duss ◽  
Asim K Duttaroy

Our understanding of platelet functionality has undergone a sea change in the last decade. No longer are platelets viewed simply as regulators of haemostasis; they are now acknowledged to be pivotal in coordinating the inflammatory and immune responses. This expanded role for platelets brings new opportunities for controlling a range of health conditions, targeting platelet activation and their interactions with other vascular cells. Antiplatelet drugs may be of wider utility than ever expected but often cause platelet suppression too strong to be used out of clinical settings. Dietary antiplatelets represent a nutritional approach that can be efficacious while safe for general use. In this review, we discuss potential new uses for dietary antiplatelets outside the field of cardiovascular health, with specific reference to the water-soluble tomato extract Fruitflow®. Its uses in different aspects of inflammation and immune function are discussed, highlighting exercise-induced inflammation, mediating the effects of air pollution, and controlling thrombotic aspects of the immune response. Potential future developments in women’s health, erectile dysfunction, and the allergic response indicate how broad the utility of dietary antiplatelets can be.


Author(s):  
Suvro Sankha Datta ◽  
Dibyendu De ◽  
Nadeem Afroz Muslim

AbstractHigh on-treatment platelet reactivity (HPR) with P2Y12 receptor antagonists in patients treated with dual antiplatelet therapy (DAPT) is strongly associated with adverse ischemic events after percutaneous coronary intervention (PCI). This prospective study was conducted to assess individual platelet response and HPR to antiplatelet medications in post-PCI cases by thromboelastography platelet mapping (TEG-PM). Total 82 patients who were on aspirin and on either clopidogrel, prasugrel, or ticagrelor were evaluated. The percentage of platelet inhibition to arachidonic acid (AA) and adenosine disdiphosphate (ADP) was calculated by [100-{(MA ADP/AA–MA Fibrin) / (MA Thrombin–MA Fibrin) × 100}], taking 50% response as cut-off for HPR. HPR to clopidogrel and prasugrel was 14.29 and 12.5%, respectively. No HPR was detected to aspirin and ticagrelor. The mean percentage of platelet inhibition was significantly higher in patients with ticagrelor 82.99, 95% confidence interval (CI) of [77.3, 88.7] as compared with clopidogrel 72.21, 95% CI of [65.3, 79.1] and prasugrel 64.2, 95% CI of [52.5, 75.9] (p-value of 0.041 and 0.003, respectively). Aspirin along with ticagrelor is associated with a higher mean percentage of platelet inhibition, and lower HPR as compared with the usage of aspirin combined with clopidogrel or prasugrel. Additionally, it might also be concluded that TEG-PM could be used effectively to measure the individual platelet functions which would make oral antiplatelet therapy more personalized for cardiac patients.


2014 ◽  
Vol 306 (11) ◽  
pp. E1248-E1256 ◽  
Author(s):  
Julie Berg Schmidt ◽  
Nikolaj Ture Gregersen ◽  
Sue D. Pedersen ◽  
Johanne L. Arentoft ◽  
Christian Ritz ◽  
...  

Our aim was to examine the effects of GLP-1 and PYY3–36, separately and in combination, on energy intake, energy expenditure, appetite sensations, glucose and fat metabolism, ghrelin, and vital signs in healthy overweight men. Twenty-five healthy male subjects participated in this randomized, double-blinded, placebo-controlled, four-arm crossover study (BMI 29 ± 3 kg/m2, age 33 ± 9 yr). On separate days they received a 150-min intravenous infusion of 1) 0.8 pmol·kg−1·min−1 PYY3–36, 2) 1.0 pmol·kg−1·min−1 GLP-1, 3) GLP-1 + PYY3–36, or 4) placebo. Ad libitum energy intake was assessed during the final 30 min. Measurements of appetite sensations, energy expenditure and fat oxidation, vital signs, and blood variables were collected throughout the infusion period. No effect on energy intake was found after monoinfusions of PYY3–36 (−4.2 ± 4.8%, P = 0.8) or GLP-1 (−3.0 ± 4.5%, P = 0.9). However, the coinfusion reduced energy intake compared with placebo (−30.4 ± 6.5%, P < 0.0001) and more than the sum of the monoinfusions ( P < 0.001), demonstrating a synergistic effect. Coinfusion slightly increased sensation of nausea ( P < 0.05), but this effect could not explain the effect on energy intake. A decrease in plasma ghrelin was found after all treatments compared with placebo (all P < 0.05); however, infusions of GLP-1 + PYY3–36 resulted in an additional decrease compared with the monoinfusions (both P < 0.01). We conclude that coinfusion of GLP-1 and PYY3–36 exerted a synergistic effect on energy intake. The satiating effect of the meal was enhanced by GLP-1 and PYY3–36 in combination compared with placebo. Coinfusion was accompanied by slightly increased nausea and a decrease in plasma ghrelin, but neither of these factors could explain the reduction in energy intake.


Stroke ◽  
2021 ◽  
Vol 52 (Suppl_1) ◽  
Author(s):  
Sarina Falcione ◽  
Gina Sykes ◽  
Joseph Kamtchum Tatuene ◽  
Danielle Munsterman ◽  
Twinkle Joy ◽  
...  

Background and Purpose: Thrombus formation is central to pathophysiology of stroke in patients with atrial fibrillation. Whether factors in plasma contribute to thrombus generation in patients with atrial fibrillation remains unclear. In this study we sought to determine whether plasma contributes to thrombin generation in patients with atrial fibrillation. Methods: There were 78 acute ischemic strokes with atrial fibrillation and 37 non-stroke controls. Plasma thrombin generation was measured by thrombin generation assay, resulting lag time, peak thrombin, time to peak and area under the curve was assessed. Thrombin generation capacity was compared in stroke patients with atrial fibrillation to non-stroke controls. The relationship to anticoagulation was assessed. In vitro, the effect of anticoagulation on plasma thrombin generation was determined. Results: Thrombin generation capacity was increased (shorter lag time and time to peak) in ischemic stroke patients with atrial fibrillation compared to non-stroke atrial-fibrillation controls (p<0.05 and p<0.01, respectively). Anticoagulation decreased plasma induced thrombin generation. Ischemic stroke patients with atrial fibrillation treated with anticoagulation (DOAC or warfarin) had lower plasma induced thrombin generation compared to atrial-fibrillation patients not on anticoagulation (p<0.05). Thrombin generation by plasma could be further reduced by DOAC in an in-vitro assay. Conclusions: Stroke patients with atrial fibrillation have a higher plasma induced thrombin generation compared to atrial fibrillation controls. Factors in plasma such as leukocyte derived tissue factor likely contribute to thrombus formation in patients with atrial fibrillation. As such, components in plasma may represent new targets to reduce thrombus formation and stroke risk in patients with atrial fibrillation.


2021 ◽  
Vol 0 (0) ◽  
Author(s):  
Robert Christie ◽  
Adrian Abel

Abstract This chapter describes the range of industrial monoazo pigments based on the 2-naphthol (β-naphthol) ring system. This group includes some of the earliest organic pigments introduced commercially and is also numerically the largest group of products currently described in the Colour Index. Most of the pigments within this group are red (with a few oranges), thus complementing the azoacetoacetanilides, which are mostly yellows. Three groups of monoazonaphthol-based pigments may be identified categorized according to the chemical structure of the coupling components used in their synthesis. The first group contains products based on 2-naphthol itself, a second is based on amide derivatives of 3-hydroxy-2-naphthoic acid (naphtharylamides), and the third is a series of metal salt azo pigments. The historical development of these pigments, outlined in an early section of this chapter, originated in the late 19th century with pigments described as ‘lakes’, derived from water-soluble anionic dyes absorbed on to inert colorless substrates, which were the forerunners of products now referred to as metal salt pigments. The non-ionic 2-naphthol-based pigments were introduced soon after. In the early to mid-20th century, a series of monoazonaphtharylamide (Naphthol AS) pigments were developed and introduced commercially. The pigments of this type that are currently manufactured can be sub-divided into products containing a single amide group (group 1) and higher performance products containing more than one amide or sulfonamide groups. Several group 1 pigments have diminished in importance over the years, while some higher performing group 2 pigments have grown in importance. The molecular and crystal structures of the range of pigments are presented and discussed in relation to their performance characteristics. The manufacture of the pigments involves the reaction of a diazotized aromatic amine with the appropriate 2-naphthol-based coupling component, using synthesis conditions typical of phenolic coupling components, followed by conditioning aftertreatments that are typical for azo pigments in general. Finally, there is an extensive discussion of the wide-ranging applications in which the individual pigments are used. While the pigments are especially well-suited to printing ink applications, many products also find use in paints and a few in plastics.


1957 ◽  
Vol 35 (1) ◽  
pp. 1277-1288
Author(s):  
William S. Bauld ◽  
Morris L. Givner ◽  
Ian G. Milne

Estrogen metabolism has been investigated in male subjects with and without previous myocardial infarction. The urinary excretion of estriol, estrone, and estradiol-17β has been measured 1 day before and 4 days after intramuscular injection of estradiol-17β. The excretion of the individual estrogens resulting from the administration of estradiol was determined by subtracting preinjection values from the daily excretion following injection. The resultant values of estriol (T), estrone (O), and estradiol-l7β (D) were expressed as the following ratios:[Formula: see text]These urinary estrogen ratios were found to be significantly higher in subjects with previous myocardial infarction than in control subjects. The ratios in the infarction group were not influenced by bed rest nor by the duration of time following infarction which varied from 1 week to 2 years.


2018 ◽  
Vol 176 ◽  
pp. 08012
Author(s):  
Rei Kudo ◽  
Tomoaki Nishizawa ◽  
Akiko Higurashi ◽  
Eiji Oikawa

For the monitoring of the global 3-D distribution of aerosol components, we developed the method to retrieve the vertical profiles of water-soluble, light absorbing carbonaceous, dust, and sea salt particles by the synergy of CALIOP and MODIS data. The aerosol product from the synergistic method is expected to be better than the individual products of CALIOP and MODIS. We applied the method to the biomass-burning event in Africa and the dust event in West Asia. The reasonable results were obtained; the much amount of the water-soluble and light absorbing carbonaceous particles were estimated in the biomass-burning event, and the dust particles were estimated in the dust event.


1974 ◽  
Vol 11 (3) ◽  
pp. 231-239 ◽  
Author(s):  
Alfred C. Lintner ◽  
Joseph Ducette

The present study investigated the responsiveness to praise of 285 elementary school pupils as a function of task variables and subject characteristics. The individual difference variables of locus of control and previous school-related failure were utilized. Analyses of the effects of praise differed considerably between an ambiguous coding and an academic reading task. Male subjects with an external locus of control orientation were responsive to praise on the coding task. Female subjects were generally not responsive, regardless of individual characteristics. Reading test residual gains, however, were affected by prior experiences of failure and praise. The results were interpreted as demonstrating the importance of integrating task variables into aptitude-treatment interaction research.


2020 ◽  
Vol 2 (1) ◽  
pp. 47
Author(s):  
Steffen Hadeler ◽  
Sebastian Bengsch ◽  
Maren S. Prediger ◽  
Marc Christopher Wurz

The resolution of commercially available electrocorticography (ECoG) electrodes is limited due to the large electrode spacing and, therefore, allows only a limited identification of the active nerve cell area. This paper describes a novel manufacturing process for neural implants with higher spatial resolution combining micro technological processes and Polydimethylsiloxane (PDMS) as the flexible, biocompatible material. The conductive electrode structure is deposited on a water-soluble transfer substrate by Physical Vapor Deposition (PVD) processes. Subsequently, the structure is contacted. Finally, the transfer to PDMS and dissolution of the transfer substrate takes place. In this way, high-resolution conductive structures can be produced on the PDMS. Transferred gold structures exhibit higher adhesion and conductivity than transferred platinum structures. The adhesion was improved by applying a silica surface modification to the conductive layer prior to transferring. Furthermore, the conductive layer is flexible, conductive up to an elongation of 10%, and resistant to sodium chloride solution, mimicking brain fluids. Using the introduced production process, an ECoG electrode was manufactured and characterized for its functionality in an electrochemical impedance measurement. Furthermore, the electrodes are flexible enough to adapt to different shapes. The transfer process can also be carried out in a three-dimensional mold to produce electrodes tailored to the individual patient.


Sign in / Sign up

Export Citation Format

Share Document